Raptiva Articles
Biogen completes US and EU filing for Amevive
8 August 2001
XOMA completes $43 million common share financing
28 June 2001
Biogen to apply for approval of Amevive
15 June 2001
Xanelim effective in psoriasis; Ph III data
30 May 2001
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
